Cargando…

Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia

Hypertension (HTN) is a global health concern due to its increasing prevalence and association with life-threatening complications. An intriguing area of investigation in HTN research is the relationship between HTN and hyperuricemia. In light of this, we conducted a review to summarize the relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ubhadiya, Tyagi J, Dubey, Nidhi, Sojitra, Mihir H, Shah, Karan, Joshi, Saumya, Gandhi, Siddharth Kamal, Patel, Priyansh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494276/
https://www.ncbi.nlm.nih.gov/pubmed/37701002
http://dx.doi.org/10.7759/cureus.43361
_version_ 1785104656046751744
author Ubhadiya, Tyagi J
Dubey, Nidhi
Sojitra, Mihir H
Shah, Karan
Joshi, Saumya
Gandhi, Siddharth Kamal
Patel, Priyansh
author_facet Ubhadiya, Tyagi J
Dubey, Nidhi
Sojitra, Mihir H
Shah, Karan
Joshi, Saumya
Gandhi, Siddharth Kamal
Patel, Priyansh
author_sort Ubhadiya, Tyagi J
collection PubMed
description Hypertension (HTN) is a global health concern due to its increasing prevalence and association with life-threatening complications. An intriguing area of investigation in HTN research is the relationship between HTN and hyperuricemia. In light of this, we conducted a review to summarize the relevant studies exploring the link between elevated serum uric acid (sUA) concentration and new-onset HTN. Through a comprehensive search of PubMed Central, MEDLINE, and PubMed databases, we identified 20 studies that met our inclusion criteria. The research encompassed various study designs, including cohort studies, cross-sectional studies, reviews, and clinical trials. Pathologically, the elevated sUA levels activate the renin-angiotensin system and also cause the formation of urate crystals, triggering inflammation in the kidneys. Additionally, direct effects on the endothelium contribute to inflammation, oxidative stress, nitric oxide depletion, and smooth muscle cell proliferation, ultimately leading to atherosclerosis. These diverse mechanisms collectively play a role in the pathogenesis of HTN. Interestingly, lowering sUA has been shown to reverse early-stage HTN dependent on uric acid. However, this effect is not observed in the uric acid-independent second stage of HTN. Various studies have demonstrated an independent and dose-dependent association between sUA levels and the prevalence of HTN across different populations and genders. The review highlights the potential role of uric acid-lowering drugs, like allopurinol, in the prevention and early-stage management of HTN. However, there is scarce research on the efficacy of other uric acid-lowering agents and combination therapies. We believe our review provides compelling evidence of the association between elevated sUA concentration and new-onset HTN. Identifying and managing hyperuricemia can provide a preventive approach to reducing the burden of HTN and its associated complications.
format Online
Article
Text
id pubmed-10494276
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104942762023-09-12 Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia Ubhadiya, Tyagi J Dubey, Nidhi Sojitra, Mihir H Shah, Karan Joshi, Saumya Gandhi, Siddharth Kamal Patel, Priyansh Cureus Family/General Practice Hypertension (HTN) is a global health concern due to its increasing prevalence and association with life-threatening complications. An intriguing area of investigation in HTN research is the relationship between HTN and hyperuricemia. In light of this, we conducted a review to summarize the relevant studies exploring the link between elevated serum uric acid (sUA) concentration and new-onset HTN. Through a comprehensive search of PubMed Central, MEDLINE, and PubMed databases, we identified 20 studies that met our inclusion criteria. The research encompassed various study designs, including cohort studies, cross-sectional studies, reviews, and clinical trials. Pathologically, the elevated sUA levels activate the renin-angiotensin system and also cause the formation of urate crystals, triggering inflammation in the kidneys. Additionally, direct effects on the endothelium contribute to inflammation, oxidative stress, nitric oxide depletion, and smooth muscle cell proliferation, ultimately leading to atherosclerosis. These diverse mechanisms collectively play a role in the pathogenesis of HTN. Interestingly, lowering sUA has been shown to reverse early-stage HTN dependent on uric acid. However, this effect is not observed in the uric acid-independent second stage of HTN. Various studies have demonstrated an independent and dose-dependent association between sUA levels and the prevalence of HTN across different populations and genders. The review highlights the potential role of uric acid-lowering drugs, like allopurinol, in the prevention and early-stage management of HTN. However, there is scarce research on the efficacy of other uric acid-lowering agents and combination therapies. We believe our review provides compelling evidence of the association between elevated sUA concentration and new-onset HTN. Identifying and managing hyperuricemia can provide a preventive approach to reducing the burden of HTN and its associated complications. Cureus 2023-08-12 /pmc/articles/PMC10494276/ /pubmed/37701002 http://dx.doi.org/10.7759/cureus.43361 Text en Copyright © 2023, Ubhadiya et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Ubhadiya, Tyagi J
Dubey, Nidhi
Sojitra, Mihir H
Shah, Karan
Joshi, Saumya
Gandhi, Siddharth Kamal
Patel, Priyansh
Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title_full Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title_fullStr Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title_full_unstemmed Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title_short Exploring the Effects of Elevated Serum Uric Acid Levels on Hypertension: A Scoping Review of Hyperuricemia
title_sort exploring the effects of elevated serum uric acid levels on hypertension: a scoping review of hyperuricemia
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494276/
https://www.ncbi.nlm.nih.gov/pubmed/37701002
http://dx.doi.org/10.7759/cureus.43361
work_keys_str_mv AT ubhadiyatyagij exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT dubeynidhi exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT sojitramihirh exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT shahkaran exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT joshisaumya exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT gandhisiddharthkamal exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia
AT patelpriyansh exploringtheeffectsofelevatedserumuricacidlevelsonhypertensionascopingreviewofhyperuricemia